nafamostat has been researched along with Infections, Helicobacter in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajikawa, H | 1 |
| Yoshida, N | 1 |
| Katada, K | 1 |
| Hirayama, F | 1 |
| Handa, O | 1 |
| Kokura, S | 1 |
| Naito, Y | 1 |
| Yoshikawa, T | 1 |
1 other study available for nafamostat and Infections, Helicobacter
| Article | Year |
|---|---|
Helicobacter pylori activates gastric epithelial cells to produce interleukin-8 via protease-activated receptor 2.
Topics: Antibodies; Benzamidines; Cell Line, Tumor; Epithelial Cells; Gastric Mucosa; Gene Expression; Guani | 2007 |